Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices 52351 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; Request; OMB No. 0925–0177 

‘‘Special Volunteer and Guest 

Researcher Assignment,’’ Form 590 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed information collection, the 

Office of Human Resources, the 

National Institutes of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection: Title: Special 

Volunteer and Guest Researcher 

Assignment for use in NIH facilities. 

Type of Information Collection 

Request: Reinstatement, OMB 0925– 

0177, Expiration Date July 31, 2005. 

Need and Use of Information 

Collection Request: 

Form Number: NIH–590. A single 

Form NIH–590 is completed by an NIH 

official for each Guest Researcher or 

Special Volunteer prior to his/her 

arrival at NIH. The information on the 

form is necessary for the approving 

official to reach a decision on whether 

to allow a Guest Researcher to use NIH 

facilities, or whether to accept volunteer 

services offered by a Special Volunteer. 

If the original assignment is extended, 

another form notating the extension is 

completed to update the file. 

Frequency of Response: Once. 

Affected Public: Individuals. 

Type of Respondents: Non-federal 

scientific professionals and/or 

individuals. 

The annual Reporting burden is as 

follows: 

Estimated Number of Respondents: 

1660; 

Estimated Number of Responses per 

Respondent: 1.0; 

Average Burden Hours per Response: 

0.1; and 

Estimated Total Annual Burden 

Hours Requested: 166. The estimated 

annualized cost to respondents is 

$2,275. 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Mrs. Wanda 

Darwin, Office of Human Resources, 

Office of The Director, NIH, Building 31, 

Room 1C31E, One Center Drive, 

Bethesda, MD 20892–2269, or call nontoll-free number 301–402–2820, or 

E-mail your request, including your 

address to: [darwinw@od.nih.gov]. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: August 18, 2010. 

Wanda R. Darwin, 

Human Resources Specialist, Office of 

Human Resources, National Institutes of 

Health. 

[FR Doc. 2010–21099 Filed 8–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; Resource for the 

Collection and Evaluation of Human 

Tissues and Cells From Donors With 

an Epidemiology Profile (NCI) 

Summary: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Cancer Institute (NCI), the National 

Institutes of Health (NIH), has submitted 

to the Office of Management and Budget 

(OMB) a request to review and approve 

the information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on June 16, 2010 (75 FR 34146) 

and allowed 60-days for public 

comment. One public comment was 

received on 7/16/2010 from a business 

informing us that they are able to 

provide a time-saving ‘‘batch processing 

service’’ to locate and verify ‘‘the most 

current addresses and phone numbers’’ 

of survey respondents. A response was 

sent on 7/26/2010 to the business which 

indicated the existence of similar 

devices and/or procedures in the 

current design of the project. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

The National Institutes of Health may 

not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Proposed Collection: Title: Resource 

for the Collection and Evaluation of 

Human Tissues and Cells from Donors 

with an Epidemiology Profile (NCI). 

Type of Information Collection Request: 

New: Need and Use of Information 

Collection: Under the auspices of three 

NCI IRB-approved protocols and 

instruments, the Laboratory of Human 

Carcinogenesis conducts case-control 

studies to investigate the relations 

between biomarkers, the environment, 

and human cancer. Human subjects 

recruited from the general population 

are needed as controls (Population 

Controls) for bio-specimens and 

personal histories (social, occupational 

and health) that serve as references for 

the significance of the frequency and 

prevalence of bio-markers found in 

cancer patients and thought to be 

important in the development, 

progression, and/or response to 

treatment of the malignant growths in 

cancer patients. The questionnaires will 

be used to obtain the personal histories 

to compare to the life styles and 

exposures and the biospecimens will 

serve as controls for the assay results 

obtained from cancer patients. The 

collection of information and specimens 

from the cancer cases received NIH 

Clinical Exemption (Request #2009–09– 

002) on October 28, 2009. Frequency of 

Response: Once. Affected Public: Adult 

and senior members of the licensed 

driver population in Baltimore, 

Maryland and eleven near-by counties, 

including the Eastern Shore. Type of 

Respondents: Responders will be 

English speaking, male and female, 

Caucasian, African-American and 

Asian. The total annual reporting 

burden is estimated to be 692 (see table 

below). There are no Capital Costs, 

Operating Costs, and/or Maintenance 

Costs to report. 


srobinson on DSKHWCL6B1PROD with NOTICES
52352 Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices 

TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Survey instrument Number of 

respondents 

Frequency of 

response 

Average time 

per response 

(minutes/hour) 

Annual burden 

hours 

Adults (40–79 years old) Telephone Screener (Attachment 16) ................. 1700 1 10/60 (0.17) 283 

Main Questionnaire (Attachment 6) ..................... 225 1 60/60 (1) 225 

Prostate Supplemental Questionnaire (Attachment 7).125 1 30/60 (0.5) 63 

Liver Supplement (Attachment 8) ........................ 225 1 30/60 (0.5) 113 

Refusal Questionnaire Form (Attachment 21) ..... 225 1 2/60 (0.03) 8 

Totals ..................... .............................................................................. 2500 ........................ ........................ 692 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact 

Glenwood E. Trivers or Elise Bowman, 

Center for Cancer Research, NCI, NIH, 

37 Convent Drive Room 3060–C or 

3060–A, Building 37, Bethesda, 

Maryland 30893–4258 or call non-tollfree number 301–496–2094 or 301–496– 

2090 or e-mail your request, including 

your address to triversg@mail.nih.gov or 

bowmane@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: August 18, 2010. 

Vivian Horovitch-Kelley 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2010–21098 Filed 8–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0079] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Experimental 

Study of Graphic Cigarette Warning 

Labels 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by September 

24, 2010. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–NEW and 

title ‘‘Experimental Study of Graphic 

Cigarette Warning Labels.’’ Also include 

the FDA docket number found in 

brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850, 301–796– 

3794, 

Jonnalynn.capezzuto@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Experimental Study of Graphic 

Cigarette Warning Labels—(OMB 

Control Number 0910–NEW) 

Tobacco products are responsible for 

more than 440,000 deaths each year. 

The Centers for Disease Control and 

Prevention report that approximately 46 

million U.S. adults smoke cigarettes in 

the United States, even though this 

behavior will result in death or 

disability for half of all regular users. 

Paralleling this enormous health burden 

is the economic burden of tobacco use, 

which is estimated to total $193 billion 

annually in medical expenditures and 

lost productivity. Curbing the 

significant adverse consequences of 

tobacco use is one of the most important 

public health goals of our time. One way 

to do this is through health warnings 

that describe and graphically depict the 

harm caused by cigarette use. 

On June 22, 2009, the President 

signed the Family Smoking Prevention 

and Tobacco Control Act (Tobacco 

Control Act) (Public Law 111–31) into 

law. The Tobacco Control Act granted 

FDA important new authority to 

regulate the manufacture, marketing, 

and distribution of tobacco products to 

protect the public health generally and 

to reduce tobacco use by minors. 

Section 201 of the Tobacco Control Act, 

which amends section 4 of the Federal 

Cigarette Labeling and Advertising Act 

(15 U.S.C. 1333), requires FDA to issue 

‘‘regulations that require color graphics 

depicting the negative health 

consequences of smoking to accompany 

the label statements specified in 

subsection (a)(1).’’ FDA conducts 

research relating to tobacco products 

under its statutory authority in section 


srobinson on DSKHWCL6B1PROD with NOTICES